NOXXON Pharma N.V., at its annual general shareholders meeting (AGM) held on June 30, 2020 appointed Dr. C. A. (Oscar) Izeboud to the supervisory board. Dr. Izeboud is CEO of Scenic Biotech, a drug discovery and development company focused on genetic modifiers, based in the Netherlands. Before joining Scenic Biotech, Dr. Izeboud was Managing Director at NIBC Bank N.V. in Amsterdam, where he headed a life sciences and healthcare team and led corporate finance and capital markets activities with a focus on innovative companies.